It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Economics and the new generation of targeted therapies for non-small cell lung cancer.
https://arctichealth.org/en/permalink/ahliterature145374
Source
J Natl Cancer Inst. 2010 Mar 3;102(5):287-8
Publication Type
Article
Date
Mar-3-2010
More detail
Author
Scott D Ramsey
Source
J Natl Cancer Inst. 2010 Mar 3;102(5):287-8
Date
Mar-3-2010
Language
English
Publication Type
Article
Keywords
Angiogenesis Inhibitors - adverse effects - economics - therapeutic use
Canada
Carcinoma, Non-Small-Cell Lung - drug therapy - economics
Cost-Benefit Analysis
Humans
Lung Neoplasms - drug therapy - economics
Protein Kinase Inhibitors - economics - therapeutic use
Protein-Tyrosine Kinases - antagonists & inhibitors
Quinazolines - adverse effects - economics - therapeutic use
Randomized Controlled Trials as Topic
United States
Notes
Comment On: J Natl Cancer Inst. 2010 Mar 3;102(5):298-30620160168
PubMed ID
20160167
View in PubMed
Less detail
Permalink